CAMBRIDGE ARTHRITIS RESEARCH ENDEAVOUR (CARE)
Supporting scientific research into rheumatological conditions, taking various forms including laboratory-based investigation of the basic mechanisms underlying diseases of the musculoskeletal system, clinical research to investigate the features and natural history of these disorders, and to improve their management and therapy, mainly in the context of randomised clinical trials.
Financial health, per its FY2025 accounts
The accounts state that unrestricted reserves fell to £300,303, which is below the charity's stated policy target of maintaining funds at £500K. The charity reported a net expenditure of £182,706 for the year, driven by charitable activities, while total income was £77,841. The independent examiner confirmed that no matters came to their attention giving cause to believe the financial statements were materially incorrect.
What the accounts disclose
“The Charity has a reserves policy to not let these funds fall below £500K.”
Trustees
- Dr FRANCES CLARE HALL
- Dr NICHOLAS GS SHENKER
- Fidelma Gordon
- His Honour Christopher Hodson
- PROFESSOR JOHN STANLEY HILL GASTON
- Professor Andrew W McCaskie
- Sarah Ramsay
- Stacey Hartshorn
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £78k | £236k |
| 31/03/2024 | £118k | £273k |
| 31/03/2023 | £295k | £193k |
| 31/03/2022 | £113k | £197k |
| 31/03/2021 | £77k | £210k |
Common questions
Is CAMBRIDGE ARTHRITIS RESEARCH ENDEAVOUR (CARE) financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted reserves fell to £300,303, which is below the charity's stated policy target of maintaining funds at £500K. The charity reported a net expenditure of £182,706 for the year, driven by charitable activities, while total income was £77,841. The independent examiner confirmed that no matters came to their attention giving cause to believe the financial statements were materially incorrect. Its FY2025 accounts were independently examined.